| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.24B | 147.57B | 142.99B | 143.04B | 115.58B | 103.25B |
| Gross Profit | 30.38B | 30.39B | 27.72B | 29.93B | 26.00B | 24.99B |
| EBITDA | 15.62B | 16.45B | 15.28B | 15.55B | 12.97B | 15.38B |
| Net Income | 4.49B | 5.96B | 6.17B | 8.59B | 5.90B | 7.12B |
Balance Sheet | ||||||
| Total Assets | 141.32B | 141.53B | 136.31B | 126.65B | 121.27B | 107.83B |
| Cash, Cash Equivalents and Short-Term Investments | 18.93B | 16.86B | 21.66B | 23.55B | 29.25B | 25.66B |
| Total Debt | 22.29B | 18.86B | 11.57B | 12.62B | 14.55B | 14.09B |
| Total Liabilities | 47.05B | 47.22B | 41.25B | 39.99B | 39.37B | 32.34B |
| Stockholders Equity | 94.26B | 94.31B | 95.05B | 86.66B | 78.73B | 72.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.98B | 3.80B | 1.80B | 5.39B | 13.18B |
| Operating Cash Flow | 0.00 | 13.68B | 12.01B | 6.70B | 9.02B | 16.25B |
| Investing Cash Flow | 0.00 | -20.91B | -10.37B | -9.61B | -4.32B | -2.23B |
| Financing Cash Flow | 0.00 | 3.19B | -5.77B | -4.63B | -2.99B | -3.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥298.55B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
70 Outperform | ¥83.56B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
67 Neutral | ¥746.10B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥267.81B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
65 Neutral | ¥236.71B | 6.13 | 1.47% | 4.29% | -7.45% | -71.68% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥707.87B | 12.79 | 2.01% | 3.82% | -4.63% | -65.11% |